🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the producers of Tylenol, claiming the firms hid potential risks that the medication presented to pediatric cognitive development.

The lawsuit follows four weeks after President Donald Trump advocated an unproven link between consuming acetaminophen - also known as acetaminophen - during pregnancy and autism in offspring.

Paxton is filing suit against Johnson & Johnson, which previously sold the drug, the exclusive pain medication recommended for expectant mothers, and Kenvue, which presently makes it.

In a statement, he said they "betrayed America by making money from pain and promoting medication without regard for the risks."

The company asserts there is insufficient reliable data connecting Tylenol to autism.

"These manufacturers lied for decades, knowingly endangering countless individuals to line their pockets," Paxton, a Republican, declared.

Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the reliability of paracetamol and the potential impact that could have on the welfare of women and children in America."

On its online platform, the company also mentioned it had "consistently assessed the pertinent research and there is no credible data that demonstrates a verified association between taking paracetamol and autism."

Organizations representing physicians and medical practitioners concur.

The leading OB-GYN organization has stated paracetamol - the primary component in Tylenol - is among limited choices for pregnant women to address discomfort and fever, which can create major wellness concerns if left untreated.

"In over twenty years of studies on the use of acetaminophen in pregnancy, not a single reputable study has definitively established that the usage of paracetamol in any stage of gestation results in neurodevelopmental disorders in offspring," the organization said.

The court filing references current declarations from the previous government in arguing the medication is reportedly hazardous.

Recently, Trump caused concern from medical authorities when he instructed women during pregnancy to "resist strongly" not to use acetaminophen when unwell.

The US Food and Drug Administration then published an announcement that medical professionals should consider limiting the use of acetaminophen, while also declaring that "a proven link" between the medication and autism spectrum disorder in children has not been established.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had promised in April to initiate "comprehensive study program" that would establish the origin of autism spectrum disorder in a matter of months.

But specialists cautioned that discovering a sole reason of autism - believed by scientists to be the consequence of a intricate combination of inherited and surrounding conditions - would be difficult.

Autism spectrum disorder is a form of enduring cognitive variation and impairment that influences how persons experience and interact with the surroundings, and is diagnosed using physician assessments.

In his legal document, Paxton - aligned with the former president who is seeking the Senate - asserts Kenvue and J&J "intentionally overlooked and tried to quiet the research" around acetaminophen and autism.

The lawsuit seeks to make the firms "eliminate any commercial messaging" that claims acetaminophen is safe for women during pregnancy.

The court case parallels the complaints of a assembly of mothers and fathers of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in 2022.

The court threw out the legal action, declaring studies from the parents' expert witnesses was inconclusive.